Kseniia Khazhylenko (Academician V. I. Grishchenko Clinic “RID”, Kyiv) on targeted immunotropic therapy — when it is evidence-based and when it is not. Antiphospholipid syndrome per ACR/EULAR 2023, functional NK-cell parameters, the ASRM 2025 guideline on recurrent pregnancy loss, and a balanced overview of agents — no “red pill”, biomarker-guided only.
Educational use only. This program is provided by Sona Academy for educational and informational purposes for healthcare professionals and students only. It is not intended for patients or the general public, is not a substitute for professional medical advice, diagnosis or treatment, and is not intended to promote the use of any products.
Funding & editorial independence. The sponsor does not participate in or influence the selection, development or content of the program. The content is developed by the speaker, and the opinions expressed are the speaker's and do not necessarily reflect those of Sona Academy or the sponsor.
Jurisdictional differences. Laws, regulations and ethical standards governing medical practice vary by country, and not all methods or techniques presented may be permissible in every jurisdiction. Users are responsible for ensuring compliance with all laws, regulations, licensing requirements and professional standards applicable in their jurisdiction.
The speaker has declared no relevant conflicts of interest in relation to this presentation.
Tell us which topics matter most to You, which learning formats You prefer, and which speakers You would like to hear from. Complete the short survey and influence future educational initiatives of Sona Academy.
-1.png&w=3840&q=75)
